|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 123.86 USD | +1.72% |
|
-0.60% | +0.71% |
| Capitalization | 151B 130B 121B 112B 210B 13,637B 226B 1,388B 546B 6,524B 567B 555B 23,904B | P/E ratio 2025 * |
18.1x | P/E ratio 2026 * | 16.3x |
|---|---|---|---|---|---|
| Enterprise value | 164B 141B 131B 122B 227B 14,799B 245B 1,506B 592B 7,079B 615B 602B 25,941B | EV / Sales 2025 * |
5.61x | EV / Sales 2026 * | 5.2x |
| Free-Float |
99.9% | Yield 2025 * |
2.73% | Yield 2026 * | 2.86% |
Last Transcript: Gilead Sciences, Inc.
| 1 day | +1.70% | ||
| 1 week | -0.60% | ||
| Current month | +0.71% | ||
| 1 month | +3.20% | ||
| 3 months | +4.33% | ||
| 6 months | +10.28% | ||
| Current year | +0.71% |
| 1 week | 119.33 |  | 125.11 |
| 1 month | 116.88 | | 127.41 |
| Current year | 116.88 | | 125.11 |
| 1 year | 90.82 | | 128.7 |
| 3 years | 62.07 | | 128.7 |
| 5 years | 57.16 | | 128.7 |
| 10 years | 56.56 | | 128.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 60 | 01/03/2019 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 01/11/2019 |
Dietmar Berger
CTO | Chief Tech/Sci/R&D Officer | 64 | 02/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 19/08/2016 |
| Director/Board Member | 73 | 01/01/2018 | |
| Director/Board Member | 72 | 09/05/2018 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -2.61% | 13.99% | 303 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.72% | -0.60% | +35.84% | +44.73% | 151B | |
| -0.38% | -3.34% | +43.79% | +199.41% | 964B | |
| +2.37% | +5.28% | +50.92% | +26.74% | 515B | |
| +0.63% | -5.15% | +26.12% | +44.87% | 390B | |
| +0.94% | +4.30% | +29.90% | +17.96% | 363B | |
| +2.41% | +2.19% | +32.56% | +23.08% | 292B | |
| +2.13% | +4.07% | +27.83% | +37.35% | 272B | |
| +2.71% | +1.95% | +11.11% | +0.24% | 269B | |
| -1.32% | +3.23% | -36.14% | -20.59% | 265B | |
| +1.15% | -4.25% | +22.47% | +21.41% | 175B | |
| Average | +1.13% | +1.25% | +24.44% | +39.52% | 365.61B | |
| Weighted average by Cap. | +0.89% | +1.51% | +29.90% | +68.96% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 29.21B 25.07B 23.34B 21.72B 40.53B 2,637B 43.7B 268B 106B 1,262B 110B 107B 4,623B | 30.17B 25.89B 24.11B 22.43B 41.86B 2,724B 45.13B 277B 109B 1,303B 113B 111B 4,775B |
| Net income | 8.05B 6.9B 6.43B 5.98B 11.16B 726B 12.04B 73.92B 29.08B 347B 30.18B 29.56B 1,273B | 8.9B 7.64B 7.11B 6.62B 12.35B 803B 13.31B 81.75B 32.16B 384B 33.38B 32.69B 1,408B |
| Net Debt | 12.87B 11.04B 10.28B 9.57B 17.85B 1,162B 19.25B 118B 46.5B 556B 48.26B 47.27B 2,036B | 5.75B 4.94B 4.6B 4.28B 7.98B 520B 8.61B 52.86B 20.8B 249B 21.58B 21.14B 911B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/01/26 | 123.61 $ | +1.52% | 2,287,652 |
| 13/01/26 | 121.76 $ | -0.69% | 5,803,884 |
| 12/01/26 | 122.60 $ | +1.24% | 7,397,037 |
| 09/01/26 | 121.10 $ | +0.36% | 6,629,526 |
| 08/01/26 | 120.67 $ | -2.96% | 6,717,804 |
Delayed Quote Nasdaq, January 15, 2026 at 12:24 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition